albuterol has been researched along with Transient Tachypnea of Newborn in 5 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although transient tachypnea of the newborn is usually a self-limited condition, it is associated with wheezing syndromes in late childhood." | 2.72 | Salbutamol for transient tachypnea of the newborn. ( Bruschettini, M; Calevo, MG; Macchi, M; Moresco, L, 2021) |
| "Although transient tachypnea of the newborn is usually a self limited condition, it is associated with wheezing syndromes in late childhood." | 2.53 | Salbutamol for transient tachypnea of the newborn. ( Bruschettini, M; Calevo, MG; Cohen, A; Gaiero, A; Moresco, L, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basiri, B | 1 |
| Sadeghi, N | 1 |
| Sabzehei, MK | 1 |
| Ashari, FE | 1 |
| Moresco, L | 2 |
| Bruschettini, M | 2 |
| Macchi, M | 1 |
| Calevo, MG | 2 |
| Malakian, A | 1 |
| Dehdashtian, M | 1 |
| Aramesh, MR | 1 |
| Aletayeb, MH | 1 |
| Heidari, S | 1 |
| Cohen, A | 1 |
| Gaiero, A | 1 |
| Buchiboyina, A | 1 |
| Jasani, B | 1 |
| Deshmukh, M | 1 |
| Patole, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Prevalence of Persistent Pulmonary Hypertension in Term and Near-term Neonates - Observational Study[NCT03499418] | 0 participants (Actual) | Observational [Patient Registry] | 2020-10-01 | Withdrawn (stopped due to Due to changing methodology of the study) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for albuterol and Transient Tachypnea of Newborn
| Article | Year |
|---|---|
Salbutamol for transient tachypnea of the newborn.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Continuous Positive Airway Pressure; Humans; Infant, | 2021 |
Salbutamol for transient tachypnea of the newborn.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Humans; Infant, Newborn; Nebulizers and Vaporizers; | 2016 |
Strategies for managing transient tachypnoea of the newborn - a systematic review.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Diuretics; Epinephrine; Female; Furose | 2017 |
2 trials available for albuterol and Transient Tachypnea of Newborn
| Article | Year |
|---|---|
Effects of Inhaled Salbutamol on Transient Tachypnea of the Newborn.
Topics: Albuterol; Humans; Infant, Newborn; Length of Stay; Respiratory Rate; Transient Tachypnea of the New | 2022 |
The effect of inhaled salbutamol on the outcomes of transient tachypnea of the newborn.
Topics: Administration, Inhalation; Adult; Albuterol; Continuous Positive Airway Pressure; Female; Humans; I | 2018 |